MDMA-Assisted Therapy Equivalency Exam

Fast track to Practical Applications by demonstrating your skills and knowledge from prior training and experience in psychedelic-assisted therapy.


MDMA-Assisted Therapy Equivalency Exam

individualized schedules
$399 CAD + tax

Course Description

If you have received extensive prior training in psychedelic-assisted therapy (i.e MAPS) and have received approval from the Numinus Training department, you will be eligible to register for this equivalency exam. Please note that this equivalency exam is reserved for highly skilled practitioners and will test various competencies to ensure you meet the necessary skills required to be successful in our Practical Applications course.

Time Commitments



In order to register for this exam, you must have:

  • Extensive prior training in psychedelic-assisted therapy (i.e MAPS training)

If you do not meet these prerequisites, please reach out to for recommendations to support you. If you are looking to start your certification journey for psychedelic-assisted therapy with Numinus, please visit our certification pathway information page.

Learning Outcomes

After successfully completing this exam, you will have demonstrated that you are able to:

  • Categorize psychedelics according to their shared properties, effects, and primary mechanism of action.
  • Compare the outcomes of psychedelic-assisted therapy and traditional psychopharmacological therapy.
  • Outline key historical events that have contributed to the development of psychedelic-assisted therapy.
  • List key studies that have investigated the outcomes of psychedelic-assisted therapy.
  • Describe the potential for risk of using psychedelic medicines inside and outside of a clinical setting.
  • Describe the unique vulnerabilities of clients participating in psychedelic-assisted therapy and cultivate the awareness and practices necessary to meet these vulnerabilities safely and ethically.
  • Apply and demonstrate relevant facilitation competencies, skills, and orientations (including the Numinus care model) at an introductory level for the purposes of delivering psychedelic-assisted therapy.
  • Describe the Numinus guiding principles within the context of integrative and transformative mental wellness as they relate to psychedelic-assisted therapy.
  • Apply facilitation skills specific to psychedelic-assisted therapy during Preparation Sessions, Medicine Sessions, and Integration Sessions.
  • Identify and respond to burnout, vicarious trauma, transference, and countertransference experienced by the health professional.
  • Determine the symptoms and appropriate treatments for the conditions presented.
  • Integrate different perspectives regarding assessment and treatment approaches applied to psychedelic-assisted therapy.
  • Discuss key psychedelic-assisted therapy research and proposed therapeutic mechanisms.
  • Apply best practices for preparation, medicine, and integration sessions.
  • Assess client’s suitability for treatment according to relative and absolute contraindications.
  • Identify potential challenges and risks associated with these disorders and limitations of psychedelic-assisted therapy as a brief intervention.
  • Apply pharmacological knowledge of MDMA to the facilitation or development of a psychedelic-assisted therapy protocol in a clinical setting.
  • Compare the wide range of effects, side effects, effects of long-term use, and abuse potential of MDMA.
  • Apply cultural safety and humility to the administration of MDMA as part of psilocybin-assisted therapy in order to avoid cultural appropriation and cultural harm.
  • Screen clients and determine if MDMA would be best suited for a given client or clinical presentation.
Watch Course Video

Review Module

In this module, you will review key concepts and competencies that were introduced in Introduction to Psychedelics, Fundamentals of Psychedelic-Assisted Therapy, Applied Psychedelic-Assisted Therapy, and Molecular Foundations.

Equivalency Exam: Part 1

In part 1 of the exam, you will complete a written exam which consists of 50 multiple choice and 3 case-based questions questions that test your knowledge and application of skills and concepts from the courses you're challenging.

Equivalency Exam: Part 2

In part 2 of the exam, you will complete a written or video-recorded reflection where you will demonstrate that you possess the necessary competencies and orientations for health professionals working with psychedelic-assisted therapy, as outlined in the Numinus Therapeutic Stance and the Numinus Care Model.



Frequently Asked Questions

Will a certificate of completion be offered to participants?

After successfully completing the exam, you will receive a certificate of completion, however this certificate cannot be claimed for continuing education credit with your licensing body.

Can I take the exam even if I live outside of Canada?

Yes, just be mindful of the time zones! Please also note that daylight saving time in North America typically comes into effect on different dates than some other parts of the world.

Please also note that while this exam can be completed from anywhere, the subsequent Practical Applications course is in person.

What are Numinus' training policies?

Please consult the Numinus Training Policies for more information about our policies.

Is this exam eligible for continuing education credit?

No, this exam and the review content are not eligible for continuing education credit.

What grade do I need to pass the exam?

In order to pass the exam, you need to achieve 80% or higher. If you achieve 70-79%, you will be eligible to rewrite the exam once to achieve 80% or higher. If you achieve less than 70%, you will need to take the full certification pathway.

Still have questions?

We’re happy to help. Send us an e-mail at

Learn More About This Course

Ask your questions, stay up to date on upcoming trainings and be a part of a community of like minded mental health professionals.

Training Interest Form


This continuing professional development program in no way promotes, condones, or facilitates illegal activity, and is strictly for educational and harm reduction purposes. Please be aware that certain psychedelic substances remain illegal in many jurisdictions, including Canada. This program and the contents of this website do not constitute medical advice, and are not a substitute for professional medical advice and treatment.

fill out this form and begin your training


Thanks for registering for MDMA-Assisted Therapy Equivalency Exam. You’ll receive a confirmation email shortly which will prompt you to set up an account on Numinus’ training platform.

Thank you for your interest in Numinus Training Programs! We noticed that you’re hoping to register for . It looks like you currently do not have the required prerequisite courses at this time. A member of our team will contact you shortly to review your registration. If you have any questions in the meantime, don’t hesitate to email us at Thank you!

Call us toll-free 1-833-NUMINUS (686-4687)
crosschevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram